Less is more: Will hypofractionated radiotherapy negatively affect cancer centers or be a godsend in the new health care environment?

ONCOLOGY (United States)

Volumn 26, Issue 6, 2012, Pages

  Konski, Andre A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; GROSS NATIONAL PRODUCT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MEDICARE; METASTASIS; PATIENT SAFETY; PROSTATE ADENOCARCINOMA; REIMBURSEMENT; REVIEW; STEREOTACTIC BODY RADIATION THERAPY;

EID: 84874796295     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Centers for Medicare and Medicaid Services. National health expenditures fact sheet. Available from: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trend s-and-Reports/NationalHealthExpendData/. Accessed May 21, 2012.
2. Centers for Medicare and Medicaid Services. Physician fee schedule: overview. Available from: http://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Accessed May 22, 2012.
3. Sethukavalan P, Cheung P, Tang CI, et al. Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy. Can J Urol. 2012;19:6165-9.